Latest News in the pharma Industry
Market News
Recro eyes expansion to full-service CDMO status
11 Aug 2021
The solid oral dose specialist signs letter of intent for acquisition of a CDMO providing a full range of services
Read more
Moderna to build mRNA vaccine manufacturing facility in Canada
11 Aug 2021
The new facility will provide access to domestically manufactured vaccines against respiratory viruses
Read more
5 Things We Learned from the CPhI North America Content Program
10 Aug 2021
The CPhI North America exhibition is taking place in-person this week in Philadelphia from 10-12 August. Here we take a look at key learnings from the past two weeks of expert-led content, available to all attendees as part of the hybrid event experien...
Read more
Bora Pharmaceuticals and KYOWA agree generic manufacturing contract
10 Aug 2021
KYOWA Pharmaceutical Industry will be the CDMO's first Japanese client for its Zhunan manufacturing site
Read more
Heraeus completes additional production line for platinum-based HPAPIs
10 Aug 2021
The expansion is Heraeus’ response to increasing global demand for these products in cancer treatment
Read more
Cosmetics packaging needs to respond to increasing consumer awareness of sustainability: CPhI Webinar panel
3 Aug 2021
The cosmetics packaging sector will need to respond to increasing consumer awareness of climate change by transitioning from fossil-based materials to long-term carbon neutral and carbon negative alternatives, according to industry experts speaking at ...
Read more
Tech transfer: a many-layered artform that demands precision and communication
3 Aug 2021
Tech transfer is a crucial phase that converts clinical promise into commercial gain but pressure on sponsors to reduce time to market in the age of COVID-19 means CDMOs have to be on top of their game to deliver. What are the latest innovations to sol...
Read more
DisperSol signs up Catalent for manufacturing of multiple pharma products
4 Aug 2021
The collaboration will see Catalent install a commercial-scale KinetiSol technology manufacturing line at its Somerset, New Jersey, facility
Read more
WuXi STA completes acquisition of its first European facility
4 Aug 2021
The purchase of BMS's Couvet, Switzerland facility adds commercial-scale production capacity for capsule and tablet dosage forms
Read more
Viatris and Biocon score historic first for interchangeable biosimilar product
2 Aug 2021
The new approval of Semeglee allows pharmacy-level substitution for Lantus across the US
Read more
Diversification and addition of capabilities key to CDMO success as end markets grow: CPhI North America panel
29 Jul 2021
CDMOs need to diversify and expand their capabilities to take full advantage of strong growth in prominent end markets such as small molecule, monoclonal antibodies and cell and gene therapy, according to an industry expert on a panel at the CPhI North...
Read more
Sartorius extends its cell culture media business via acquisition
2 Aug 2021
Acquiring Xell AG will enable Sartorius to offer specialised media for manufacturing viral vectors
Read more